Cargando…
Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the Apolipoprotein A5 gene
OBJECTIVE: Type III Hyperlipoproteinemia is a rare lipid disorder with a frequency of 1-5 in 5000. It is characterized by the accumulation of triglyceride rich lipoproteins and patients are at increased risk of developping atherosclerosis. Type III HLP is strongly associated with the homozygous pres...
Autores principales: | Evans, D, Bode, A, von der Lippe, G, Beil, FU, Mann, WA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353427/ https://www.ncbi.nlm.nih.gov/pubmed/21463987 http://dx.doi.org/10.1186/2047-783X-16-2-79 |
Ejemplares similares
-
The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III Hyperlipidemia
por: Evans, David, et al.
Publicado: (2007) -
Atherosclerosis and Cerebrovascular Diseases
por: Blaton, Victor
Publicado: (2004) -
Association between apolipoprotein gene polymorphisms and hyperlipidemia: a meta-analysis
por: Zhao, Xiao-Ning, et al.
Publicado: (2021) -
ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis
por: Mohamed, Farzahna, et al.
Publicado: (2022) -
Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes
por: Fan, Dabei, et al.
Publicado: (2018)